MLchartDataset catalogue

Tepmetko

Term · Oncology and biomedicine · MLC-T-ONC-008591

A drug used to treat adults with non-small cell lung cancer that has spread to other parts of the body and has a certain mutation (change) in the MET gene. It is also being studied in the treatment of other types of cancer. Tepmetko blocks a protein made by the MET gene, which may help keep cancer cells from growing and spreading and may kill them. It is a type of tyrosine kinase inhibitor. Also called tepotinib hydrochloride.

Table 1. Record
IdentifierMLC-T-ONC-008591
FieldOncology and biomedicine
Synonymstepotinib hydrochloride
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008591",
  "term": "Tepmetko",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with non-small cell lung cancer that has spread to other parts of the body and has a certain mutation (change) in the MET gene. It is also being studied in the treatment of other types of cancer. Tepmetko blocks a protein made by the MET gene, which may help keep cancer cells from growing and spreading and may kill them. It is a type of tyrosine kinase inhibitor. Also called tepotinib hydrochloride.",
  "synonyms": [
    "tepotinib hydrochloride"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/tepmetko/"
}

Record 16,147 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.